Anebulo Pharmaceuticals Reports Positive Data from Trial of Cannabinoid Intoxication Treatment; Shares Jump


MT Newswires 2023

All news about ANEBULO PHARMACEUTICALS, INC.

Analyst Recommendations on ANEBULO PHARMACEUTICALS, INC.

Sales 2023

Net income 2023 -14,9 M

Net Debt 2023

P/E ratio 2023 -4,94x
Yield 2023
Capitalization 74,1 M
74,1 M
Capi. / Sales 2023
Capi. / Sales 2024
Nbr of Employees 4
Free-Float 31,0%

Chart ANEBULO PHARMACEUTICALS, INC.



Duration :


Period :




Anebulo Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener

Income Statement Evolution

Sell

Buy

Mean consensus BUY
Number of Analysts 2
Last Close Price 2,89 $
Average target price 7,00 $
Spread / Average Target 142%


Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *